Phase II trial of piperazinedione in the treatment of advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group Study.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/ADF2EE95.svg?ark=w1%2F20260515%2FADF2EE95)](https://nobleid.org/work/w1/20260515/ADF2EE95)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors